Literature DB >> 10647119

D-arabinitol--a marker for invasive candidiasis.

B Christensson1, G Sigmundsdottir, L Larsson.   

Abstract

The five-carbon sugar alcohol D-arabinitol (DA) is a metabolite of most pathogenic Candida species, in vitro as well as in vivo, and can be determined by gas chromatography or enzymatic analysis. Endogenous DA and L-arabinitol (LA) are present in human body fluids, and serum DA and LA increase in renal dysfunction. In prospective clinical studies, elevated DA/LA or DA/creatine ratios in serum or urine have been found in immunocompromised, usually neutropenic, patients with invasive candidiasis. In addition, positive DA results have been obtained several days to weeks before positive blood cultures, and the normalization of DA levels has been correlated with therapeutic response in both humans and animals. However, to date, only a few prospective studies have been conducted in which adequate analytical methods were used. Thus, further investigation of various patient groups is needed to establish the applicability of the 'arabinitol method' in the diagnostic battery for invasive Candida infections.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10647119     DOI: 10.1046/j.1365-280x.1999.00249.x

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  8 in total

Review 1.  Prophylaxis and treatment of invasive candidiasis in the intensive care setting.

Authors:  L Ostrosky-Zeichner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

2.  Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis.

Authors:  Annie Philip; Zekaver Odabasi; Gloria Matiuzzi; Victor L Paetznick; Sze-Wee Tan; John Warmington; John H Rex; Luis Ostrosky-Zeichner
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Measurement of serum D-arabinitol/creatinine ratios for initial diagnosis and for predicting outcome in an unselected, population-based sample of patients with Candida fungemia.

Authors:  Siew Fah Yeo; Sharon Huie; Andre N Sofair; Sheldon Campbell; Amanda Durante; Brian Wong
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

Review 4.  Current status of nonculture methods for diagnosis of invasive fungal infections.

Authors:  Siew Fah Yeo; Brian Wong
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

5.  A novel molecular imprinting polymer for the selective adsorption of D-arabinitol from spiked urine.

Authors:  Yuni Retnaningtyas; Ganden Supriyanto; Ni Nyoman Tri Puspaningsih; Roedi Irawan; Siswandono Siswodihardjo
Journal:  Turk J Chem       Date:  2020-10-26       Impact factor: 1.239

Review 6.  Use of recombinant antigens for the diagnosis of invasive candidiasis.

Authors:  Ana Laín; Natalia Elguezabal; Elena Amutio; Iñigo Fernández de Larrinoa; María Dolores Moragues; José Pontón
Journal:  Clin Dev Immunol       Date:  2008

7.  Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.

Authors:  Fasahat F Alam; Abu S Mustafa; Zia U Khan
Journal:  BMC Infect Dis       Date:  2007-09-04       Impact factor: 3.090

8.  Serological response and diagnostic value of recombinant candida cell wall protein enolase, phosphoglycerate kinase, and β-glucosidase.

Authors:  Zheng-Xin He; Jing Chen; Wei Li; Yan Cheng; Hai-Pu Zhang; Li-Na Zhang; Tian-Wen Hou
Journal:  Front Microbiol       Date:  2015-09-10       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.